AI assistant
Sending…
Sopharma AD — Earnings Release 2020
Mar 5, 2020
2543_rns_2020-03-05_254e1d94-cbf7-40d5-93bd-f758054a039a.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report №6/ 2020 Dated March 5, 2020
NOTIFICATION
Sopharma AD (the "Company") notifies that for February 2020 the Company recorded a decrease in sales of 22% compared to the same month of 2019, incl. 1% decrease in sales for the domestic market and 30% decrease in export sales.
In the first two months of 2020 the revenues from sales of production decreased by 15% compared to the same period of 2019, incl. 2% decrease in domestic sales and 20% increase in export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19